Search

everythinglearnresearchcommunity

for

Search:↓

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Erythropoietin helps hair grow and could be a potential treatment for hair loss.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Technique effectively reconstructs large scalp defects with minimal hair loss and visible scarring.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

HFMs can help study hair growth and test potential hair growth drugs.

Menopause affects hair and skin; more research needed for treatment.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

The conclusion is that understanding how feathers and hairs pattern can help in developing hair regeneration treatments.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

New methods to test hair growth treatments have been developed.

PRP treatment helps hair growth in most cases, but more research needed.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The UK Intellectual Property Office allows granting of supplementary protection certificates with negative terms.